Global HEOR Services Market – Industry Overview and Forecast to 2032

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Global HEOR Services Market – Industry Overview and Forecast to 2032

  • Healthcare
  • Upcoming Report
  • Feb 2025
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Heor Services Market

Market Size in USD Billion

CAGR :  % Diagram

Bar chart comparing the Global Heor Services Market size in 2024 - 1.24 and 2032 - 2.27, highlighting the projected market growth. USD 1.24 Billion USD 2.27 Billion 2024 2032
Diagram Forecast Period
2025 –2032
Diagram Market Size (Base Year)
USD 1.24 Billion
Diagram Market Size (Forecast Year)
USD 2.27 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global HEOR Services Market Segmentation, By Service Type (Health Economics Services, Outcomes Research Services, Consulting Services, and Data Analytics Services), Indication (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Infectious Diseases, and Other), Technology (Software Solutions, Data Management Tools, and Statistical Analysis Software), End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers, Healthcare Providers, Government Organizations, Academic Institutions, and Payers and Insurers) - Industry Trends and Forecast to 2032

HEOR Services Market

Global HEOR Services Market Analysis

The global Health Economics and Outcomes Research (HEOR) services market is experiencing significant growth driven by several factors, including the increasing emphasis on value-based healthcare and the need for robust economic evidence to support decision-making in drug development and market access. Pharmaceutical and biotechnology companies are increasingly recognizing the importance of HEOR services to demonstrate the cost-effectiveness and overall benefit of their products compared to existing therapies. The rising healthcare costs, coupled with a growing demand for transparent pricing and reimbursement processes, are steering stakeholders towards comprehensive HEOR analyses, leading to enhanced patient access to effective treatments.

In addition, the market is characterized by advancements in technology, such as the use of big data analytics and artificial intelligence, which improve the efficiency and accuracy of HEOR studies. The integration of real-world data into HEOR assessments allows for a better understanding of the long-term outcomes and economic impacts of healthcare interventions. Geographically, North America holds a dominant position in the HEOR services market due to the presence of major pharmaceutical companies and regulatory bodies emphasizing the need for health economic evaluations. However, the Asia-Pacific region is emerging as a significant market, driven by increasing healthcare expenditures, an evolving regulatory landscape, and rising awareness of the importance of HEOR in shaping healthcare policy and reimbursement decisions. Overall, the global HEOR services market is poised for continued expansion as stakeholders seek to optimize healthcare delivery and improve patient outcomes.

Global HEOR Services Market Size

Global HEOR services market size was valued at USD 1.24 billion in 2024 and is projected to reach USD 2.27 billion by 2032, with a CAGR of 10.9% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global HEOR Services  Market Trends

“Increasing Adoption of Real-World Evidence (RWE) and Real-World Data (RWD)”

One of the emerging trends in the Global Health Economics and Outcomes Research (HEOR) services market is the increasing adoption of Real-World Evidence (RWE) and Real-World Data (RWD) in HEOR studies. RWE/RWD refers to data collected from real-world sources, such as electronic health records, claims databases, and patient registries, which provide valuable insights into the effectiveness and safety of healthcare interventions in real-world settings. This trend is driven by the need for more robust and generalizable evidence to support healthcare decision-making, as traditional randomized controlled trials (RCTs) may not fully capture the complexities of real-world healthcare settings. As a result, pharmaceutical and biotechnology companies, payers, and regulatory agencies are increasingly leveraging RWE/RWD to inform their pricing and reimbursement decisions, market access strategies, and product development pipelines, leading to a significant growth in demand for HEOR services that incorporate RWE/RWD.

Global HEOR Services  Market Segmentation 

Attributes

Global HEOR Services  Market Insights

Segments Covered

  • By Service Type: Health Economics Services, Outcomes Research Services, Consulting Services, and Data Analytics Services
  • By Indication: Oncology, Cardiovascular Diseases, Diabetes, Neurology, Infectious Diseases, and Other
  • By Technology: Software Solutions, Data Management Tools, and Statistical Analysis Software
  • By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers, Healthcare Providers, Government Organizations, Academic Institutions, and Payers and Insurers

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America

Key Market Players

IQVIA (U.S.), Covance (Labcorp) (U.S.), Optum (UnitedHealth Group) (U.S.), Celerion (U.S.), Purdue Pharma (U.S.), Analysis Group (U.S.), Evidera (U.S.), Kantar Health (U.S.), Xcenda (U.S.), Avalere Health(U.S.), Payer & Value-Based Solutions, Inc. (PVBS) (U.S.), Deloitte(U.S.), McKinsey & Company(U.S.), Guidance Document(U.S.), and Syneos Health (U.S.)

Market Opportunities

  • Increasing Demand for Real-World Evidence
  • Rising Healthcare Costs

Value Added Data Infosets

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global HEOR Services Market Definition

Health Economics and Outcomes Research (HEOR) Service refers to a specialized set of analytical and research services aimed at evaluating the economic, clinical, and patient-centered outcomes of healthcare interventions, such as medications, medical devices, and treatment protocols. HEOR services are designed to provide evidence-based insights into the value, efficacy, and cost-effectiveness of healthcare solutions. They help healthcare stakeholders, including pharmaceutical companies, payers, providers, and policymakers, make informed decisions about resource allocation, reimbursement strategies, and market access.                 

Global HEOR Services Market  

Drivers

  • Rising Healthcare Costs

Rising healthcare costs represent a significant and multifaceted challenge faced by healthcare systems globally, primarily driven by factors such as increased prevalence of chronic diseases, advancements in medical technologies, and aging populations. These escalating expenses compel stakeholders—including governments, insurers, and healthcare providers—to seek evidence-based solutions that can ensure efficient allocation of resources while maintaining or improving patient outcomes. As the financial burden of healthcare amplifies, there is a heightened demand for Health Economics and Outcomes Research (HEOR) services to evaluate the cost-effectiveness of new treatments and interventions, ultimately guiding decisions on reimbursement, formulary inclusion, and clinical pathways. HEOR analysis helps demonstrate the value of healthcare solutions by comparing the costs and health outcomes relative to existing alternatives, thereby enabling a more sustainable approach to healthcare financing. This environment necessitates the integration of HEOR into strategic planning and policy-making, as payers and providers increasingly look for justifications for funding new therapeutics based on their economic impact and overall value to the healthcare system.

  • Value-Based Healthcare Models

Value-Based Healthcare (VBHC) models prioritize the delivery of high-quality healthcare that improves patient outcomes while controlling costs, shifting the focus from volume of services provided to the value generated from those services. In these models, reimbursement and provider incentives are linked to the effectiveness of treatments rather than the quantity of services rendered. This approach emphasizes the importance of patient-centered care, where clinical effectiveness, patient satisfaction, and overall health outcomes are key determinants in evaluating healthcare performance. By leveraging detailed patient data and health economics, VBHC aims to ensure that interventions deliver meaningful health benefits relative to their costs, fostering a more efficient healthcare system that rewards providers for achieving better health outcomes. Ultimately, VBHC models aspire to create a sustainable healthcare ecosystem that maximizes both patient quality of life and the efficient use of healthcare resources.

Opportunities

  • Increased Demand for Cost-Effectiveness Analysis

Increased demand for cost-effectiveness analysis (CEA) refers to the growing need for systematic evaluations that compare the relative costs and outcomes of different healthcare interventions, ensuring that resources are allocated efficiently to maximize health benefits. This trend is driven by the rising pressure on healthcare systems to control costs while improving patient outcomes, especially in the context of high-priced pharmaceuticals and novel treatments. Policymakers, payers, and healthcare providers seek evidence-based assessments to inform coverage decisions, prioritize funding, and optimize treatment pathways. As healthcare becomes increasingly data-driven and value-centric, CEA serves as a vital tool in demonstrating the economic viability of interventions, thereby supporting the transition to value-based healthcare models that emphasize quality over quantity in service delivery.

  • Rising Importance of Value-Based Healthcare

The rising importance of value-based healthcare represents a transformative shift in how healthcare systems assess the effectiveness and efficiency of medical interventions, prioritizing patient outcomes relative to costs rather than the volume of services provided. This model emphasizes delivering superior care that not only alleviates symptoms but also improves overall quality of life for patients, aligning provider incentives with patient-centered outcomes. As healthcare payers and providers increasingly recognize the limitations of fee-for-service models, they are adopting value-based approaches that reward high-quality care and encourage the use of evidence-based practices. This shift necessitates robust health economics and outcomes research (HEOR) to evaluate the real-world effectiveness of therapies and inform decisions regarding reimbursement, thereby positioning value-based healthcare as a crucial strategy in achieving sustainable health systems and enhanced patient care.

Restraints/Challenges

  • Regulatory Challenges

Regulatory challenges in the context of healthcare, particularly in Health Economics and Outcomes Research (HEOR), refer to the complex landscape of laws, guidelines, and standards that govern the approval, implementation, and reimbursement of healthcare interventions across different regions. These challenges often arise from the variability in regulatory frameworks among countries, which can create inconsistencies in how health technologies and clinical outcomes are evaluated and utilized. Manufacturers and researchers must navigate an intricate process of obtaining necessary approvals, adhering to ethical standards, and ensuring compliance with local regulations, all of which can be time-consuming and resource-intensive. In addition, evolving regulatory requirements and the need for robust evidence to support value propositions can further complicate the process, potentially delaying market access and limiting the adoption of innovative healthcare solutions.

  • High Costs

High costs in the context of Health Economics and Outcomes Research (HEOR) refer to the significant financial expenditures associated with conducting comprehensive studies that evaluate the economic impact and clinical outcomes of healthcare interventions. These costs can stem from several factors, including the need for large-scale data collection, advanced analytical tools, specialized expertise, and the collaboration required among multiple stakeholders. Moreover, extensive longitudinal studies often require substantial investments in technology and personnel, which can exceed the budgets of smaller firms or startups. Consequently, the financial burden of HEOR can limit access to valuable insights, deter investment in research initiatives, and potentially restrict the ability of healthcare organizations to inform decision-making and demonstrate the value of their products and services effectively.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global HEOR Services Market Scope

The market is segmented on the basis of service type, indication, technology, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Service Type

  • Health Economics Services
  • Outcomes Research Services
  • Consulting Services
  • Data Analytics Services

Indication

  • Oncology
  • Cardiovascular Diseases
  • Diabetes
  • Neurology
  • Infectious Diseases
  • Other

Technology

  • Software Solutions
  • Data Management Tools
  • Statistical Analysis Software

End User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Manufacturers
  • Healthcare Providers
  • Government Organizations
  • Academic Institutions
  • Payers and Insurers

Global HEOR Services Market Regional Analysis

The market is analysed and market size insights and trends are provided of country, service type, indication, technology, and end user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the global HEOR services market due to its extensive healthcare infrastructure, advanced research capabilities, and strong regulatory frameworks that facilitate innovation. The region is home to numerous leading pharmaceutical and biotechnology companies, which invest heavily in HEOR to support product development and market access strategies. In addition, the presence of well-established academic institutions and research organizations fosters a robust environment for HEOR research, contributing to the generation of valuable data that informs policy and healthcare decisions. The high demand for evidence-based outcomes from payers, healthcare providers, and patients in North America further drives the growth of HEOR services, as stakeholders seek to understand the economic value and impact of healthcare interventions. Consequently, this combination of factors positions North America as a leader in the HEOR landscape, influencing global trends and practices.

Asia-Pacific is experiencing rapid growth due to several critical factors, including rapid economic growth, increasing healthcare expenditures, and a rising emphasis on evidence-based medicine across the region. The expansion of healthcare markets in countries like China and India has led to a burgeoning demand for comprehensive health data analytics to assess the value of new treatments and innovations. In addition, the growing prevalence of chronic diseases and an aging population have prompted governments and healthcare payers to prioritize cost-effective healthcare solutions, further fueling the need for robust HEOR services. The region's increasing collaboration between governmental bodies, healthcare providers, and pharmaceutical companies has enhanced the development of local expertise and methodologies tailored to unique market needs. As a result, Asia Pacific stands to play a crucial role in shaping the global HEOR landscape, driving advancements in research and the application of health economics to improve healthcare outcomes.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Global HEOR Services Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Global HEOR Services Market Leaders Operating in the Market Are:

  • IQVIA (U.S.)
  • Covance (Labcorp) (U.S.)
  • Optum (UnitedHealth Group) (U.S.)
  • Celerion(U.S.)
  • Purdue Pharma(U.S.)
  • Analysis Group(U.S.)
  • Evidera(U.S.)
  • Kantar Health(U.S.)
  • Xcenda(U.S.)
  • Avalere Health(U.S.)
  • Payer & Value-Based Solutions, Inc. (PVBS) (U.S.)
  • Deloitte(U.S.)
  • McKinsey & Company(U.S.)
  • Guidance Document(U.S.)
  • Syneos Health(U.S.)

Latest Developments in Global HEOR Services Market

  • ​In January 2024, The Professional Society for Health Economics and Outcomes Research announced an expanded editorial scope and plans to transition its journal to a gold open access model
  • In December 2023, Komodo Health was selected by the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington’s School of Pharmacy to collaborate on generating real-world insights. The partnership focuses on comparative outcomes and cost-effectiveness research and analytics within the U.S.
  • In November 2023, Fishawack Health (FH), a leading commercialization partner for biopharmaceutical, medical technology, and wellness companies, expanded its Value, Evidence, and Access (VEA) capabilities through the acquisition of Policy Analysis Inc. (PAI), a U.S.-based health economics and outcomes research (HEOR) consultancy
  • In November 2023, Curavit Clinical Research, a virtual contract research organization (VCRO), launched a tailored Health Economics and Outcomes Research (HEOR) service for clinical trials. By integrating HEOR into clinical trials, Curavit aims to provide pharmaceutical manufacturers with crucial insights into their products' value and market potential
  • In May 2022, Trinity Life Sciences initiated a project to examine the impact of significant advancements and growth in Health Economics and Outcomes Research (HEOR) within the U.S.
  • In May 2022, Cigna, a leading American multinational health and insurance company, introduced a new oncology consultation service aimed at improving health outcomes for its members
  • In April 2022, Snowflake Inc., a cloud computing and data storage company, launched healthcare and life sciences cloud consulting services. These services enable organizations to securely centralize, integrate, and exchange critical and sensitive data at scale


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Global HEOR Services Market Segmentation, By Service Type (Health Economics Services, Outcomes Research Services, Consulting Services, and Data Analytics Services), Indication (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Infectious Diseases, and Other), Technology (Software Solutions, Data Management Tools, and Statistical Analysis Software), End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers, Healthcare Providers, Government Organizations, Academic Institutions, and Payers and Insurers) - Industry Trends and Forecast to 2032 .
The Global HEOR Services Market size was valued at USD 1.24 USD Billion in 2024.
The Global HEOR Services Market is projected to grow at a CAGR of 10.9% during the forecast period of 2025 to 2032.
The market report covers data from U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.
Testimonial